NCT02253121 - Glucose Control During Glucocorticoid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

May 31, 2017

Conditions

Hyperglycemia Steroid-induced

Interventions

DRUG

Dapagliflozin

Dapagliflozin 10mg during glucocorticoid therapy for acute exacerbation COPD

DRUG

Sliding scale insulin

Sliding scale insulin with short acting insulin based on current glucose levels

Trial Locations (4)

Slotervaart Hospital, Amsterdam

OLVG West, Amsterdam

Spaarne Ziekenhuis, Hoofddorp

Isala, Zwolle